RAGE supports parathyroid hormone-induced gains in femoral trabecular bone

Binu K. Philip, Paul J. Childress, Alexander Robling, Aaron Heller, Peter P. Nawroth, Angelika Bierhaus, Joseph Bidwell

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Parathyroid hormone (PTH) restores bone mass to the osteopenic skeleton, but significant questions remain as to the underlying mechanisms. The receptor for advanced glycation end products (RAGE) is a multiligand receptor of the immunoglobulin superfamily; however, recent studies indicate a role in bone physiology. We investigated the significance of RAGE to hormone-induced increases in bone by treating 10-wk-old female Rage-knockout (KO) and wild-type (WT) mice with human PTH-(1-34) at 30 μg•kg-1•day -1 or vehicle control, 7 days/wk, for 7 wk. PTH produced equivalent relative gains in bone mineral density (BMD) and bone mineral content (BMC) throughout the skeleton in both genotypes. PTH-mediated relative increases in cortical area of the midshaft femur were not compromised in the null mice. However, the hormone-induced gain in femoral cancellous bone was significantly attenuated in Rage-KO mice. The loss of RAGE impaired PTHmediated increases in femoral cancellous bone volume, connectivity density, and trabecular number but did not impact increases in trabecular thickness or decreases in trabecular spacing. Disabling RAGE reduced femoral expression of bone formation genes, but their relative PTH-responsiveness was not impaired. Neutralizing RAGE did not attenuate vertebral cancellous bone response to hormone. Rage-null mice exhibited an attenuated accrual rate of bone mass, with the exception of the spine, and an enhanced accrual rate of fat mass. We conclude that RAGE is necessary for key aspects of the skeleton's response to anabolic PTH. Specifically, RAGE is required for hormone-mediated improvement of femoral trabecular architecture but not intrinsically necessary for increasing cortical thickness.

Original languageEnglish
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume298
Issue number3
DOIs
StatePublished - Mar 2010

Fingerprint

Thigh
Parathyroid Hormone
Rage
Bone and Bones
Skeleton
Hormones
Knockout Mice
Bone Density
Teriparatide
Cancellous Bone
Advanced Glycosylation End Product-Specific Receptor
Osteogenesis
Femur
Immunoglobulins
Spine
Fats
Genotype
Genes

Keywords

  • Anabolic
  • High-mobility group box 1 protein
  • Osteoblast
  • Osteoimmunology
  • Osteoporosis
  • Receptor for advanced glycation end products

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

RAGE supports parathyroid hormone-induced gains in femoral trabecular bone. / Philip, Binu K.; Childress, Paul J.; Robling, Alexander; Heller, Aaron; Nawroth, Peter P.; Bierhaus, Angelika; Bidwell, Joseph.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, No. 3, 03.2010.

Research output: Contribution to journalArticle

Philip, Binu K. ; Childress, Paul J. ; Robling, Alexander ; Heller, Aaron ; Nawroth, Peter P. ; Bierhaus, Angelika ; Bidwell, Joseph. / RAGE supports parathyroid hormone-induced gains in femoral trabecular bone. In: American Journal of Physiology - Endocrinology and Metabolism. 2010 ; Vol. 298, No. 3.
@article{e6273d2a598748c38bd5f45911e7125a,
title = "RAGE supports parathyroid hormone-induced gains in femoral trabecular bone",
abstract = "Parathyroid hormone (PTH) restores bone mass to the osteopenic skeleton, but significant questions remain as to the underlying mechanisms. The receptor for advanced glycation end products (RAGE) is a multiligand receptor of the immunoglobulin superfamily; however, recent studies indicate a role in bone physiology. We investigated the significance of RAGE to hormone-induced increases in bone by treating 10-wk-old female Rage-knockout (KO) and wild-type (WT) mice with human PTH-(1-34) at 30 μg•kg-1•day -1 or vehicle control, 7 days/wk, for 7 wk. PTH produced equivalent relative gains in bone mineral density (BMD) and bone mineral content (BMC) throughout the skeleton in both genotypes. PTH-mediated relative increases in cortical area of the midshaft femur were not compromised in the null mice. However, the hormone-induced gain in femoral cancellous bone was significantly attenuated in Rage-KO mice. The loss of RAGE impaired PTHmediated increases in femoral cancellous bone volume, connectivity density, and trabecular number but did not impact increases in trabecular thickness or decreases in trabecular spacing. Disabling RAGE reduced femoral expression of bone formation genes, but their relative PTH-responsiveness was not impaired. Neutralizing RAGE did not attenuate vertebral cancellous bone response to hormone. Rage-null mice exhibited an attenuated accrual rate of bone mass, with the exception of the spine, and an enhanced accrual rate of fat mass. We conclude that RAGE is necessary for key aspects of the skeleton's response to anabolic PTH. Specifically, RAGE is required for hormone-mediated improvement of femoral trabecular architecture but not intrinsically necessary for increasing cortical thickness.",
keywords = "Anabolic, High-mobility group box 1 protein, Osteoblast, Osteoimmunology, Osteoporosis, Receptor for advanced glycation end products",
author = "Philip, {Binu K.} and Childress, {Paul J.} and Alexander Robling and Aaron Heller and Nawroth, {Peter P.} and Angelika Bierhaus and Joseph Bidwell",
year = "2010",
month = "3",
doi = "10.1152/ajpendo.00564.2009",
language = "English",
volume = "298",
journal = "American Journal of Physiology",
issn = "0193-1857",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - RAGE supports parathyroid hormone-induced gains in femoral trabecular bone

AU - Philip, Binu K.

AU - Childress, Paul J.

AU - Robling, Alexander

AU - Heller, Aaron

AU - Nawroth, Peter P.

AU - Bierhaus, Angelika

AU - Bidwell, Joseph

PY - 2010/3

Y1 - 2010/3

N2 - Parathyroid hormone (PTH) restores bone mass to the osteopenic skeleton, but significant questions remain as to the underlying mechanisms. The receptor for advanced glycation end products (RAGE) is a multiligand receptor of the immunoglobulin superfamily; however, recent studies indicate a role in bone physiology. We investigated the significance of RAGE to hormone-induced increases in bone by treating 10-wk-old female Rage-knockout (KO) and wild-type (WT) mice with human PTH-(1-34) at 30 μg•kg-1•day -1 or vehicle control, 7 days/wk, for 7 wk. PTH produced equivalent relative gains in bone mineral density (BMD) and bone mineral content (BMC) throughout the skeleton in both genotypes. PTH-mediated relative increases in cortical area of the midshaft femur were not compromised in the null mice. However, the hormone-induced gain in femoral cancellous bone was significantly attenuated in Rage-KO mice. The loss of RAGE impaired PTHmediated increases in femoral cancellous bone volume, connectivity density, and trabecular number but did not impact increases in trabecular thickness or decreases in trabecular spacing. Disabling RAGE reduced femoral expression of bone formation genes, but their relative PTH-responsiveness was not impaired. Neutralizing RAGE did not attenuate vertebral cancellous bone response to hormone. Rage-null mice exhibited an attenuated accrual rate of bone mass, with the exception of the spine, and an enhanced accrual rate of fat mass. We conclude that RAGE is necessary for key aspects of the skeleton's response to anabolic PTH. Specifically, RAGE is required for hormone-mediated improvement of femoral trabecular architecture but not intrinsically necessary for increasing cortical thickness.

AB - Parathyroid hormone (PTH) restores bone mass to the osteopenic skeleton, but significant questions remain as to the underlying mechanisms. The receptor for advanced glycation end products (RAGE) is a multiligand receptor of the immunoglobulin superfamily; however, recent studies indicate a role in bone physiology. We investigated the significance of RAGE to hormone-induced increases in bone by treating 10-wk-old female Rage-knockout (KO) and wild-type (WT) mice with human PTH-(1-34) at 30 μg•kg-1•day -1 or vehicle control, 7 days/wk, for 7 wk. PTH produced equivalent relative gains in bone mineral density (BMD) and bone mineral content (BMC) throughout the skeleton in both genotypes. PTH-mediated relative increases in cortical area of the midshaft femur were not compromised in the null mice. However, the hormone-induced gain in femoral cancellous bone was significantly attenuated in Rage-KO mice. The loss of RAGE impaired PTHmediated increases in femoral cancellous bone volume, connectivity density, and trabecular number but did not impact increases in trabecular thickness or decreases in trabecular spacing. Disabling RAGE reduced femoral expression of bone formation genes, but their relative PTH-responsiveness was not impaired. Neutralizing RAGE did not attenuate vertebral cancellous bone response to hormone. Rage-null mice exhibited an attenuated accrual rate of bone mass, with the exception of the spine, and an enhanced accrual rate of fat mass. We conclude that RAGE is necessary for key aspects of the skeleton's response to anabolic PTH. Specifically, RAGE is required for hormone-mediated improvement of femoral trabecular architecture but not intrinsically necessary for increasing cortical thickness.

KW - Anabolic

KW - High-mobility group box 1 protein

KW - Osteoblast

KW - Osteoimmunology

KW - Osteoporosis

KW - Receptor for advanced glycation end products

UR - http://www.scopus.com/inward/record.url?scp=77349111934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77349111934&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00564.2009

DO - 10.1152/ajpendo.00564.2009

M3 - Article

C2 - 20028966

AN - SCOPUS:77349111934

VL - 298

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0193-1857

IS - 3

ER -